IFNG and cancer: Seven of the nine tested types of Tier 2 TRuC T cells could be activated to various extents as assessed by IFN-γ secretion after co-culture with cancer cells expressing low densities of the p53RH antigen (P < 0.0001; Fig. 2, B and C), unlike CAR T cells (Fig. 1, C and D).